First Time Loading...

Yield10 Bioscience Inc
NASDAQ:YTEN

Watchlist Manager
Yield10 Bioscience Inc Logo
Yield10 Bioscience Inc
NASDAQ:YTEN
Watchlist
Price: 0.25 USD -3.85% Market Closed
Updated: Dec 11, 2023

Intrinsic Value

YTEN doesn't have a meaningful market cap.

Valuation History
Yield10 Bioscience Inc

Historical Profit
Current Valuation
Price & Value Correlation
Value CAGR
Calculating
Intrinsic Value History...

Our system is conducting in-depth analyses to map out the stock's valuation journey. Thank you for waiting.

Fundamental Analysis

Financials
NEW
NEW

Balance Sheet Decomposition
Yield10 Bioscience Inc

Current Assets 3.4m
Cash & Short-Term Investments 2.8m
Other Current Assets 600k
Non-Current Assets 2.6m
PP&E 2.4m
Other Non-Current Assets 200k
Current Liabilities 4m
Accounts Payable 400k
Accrued Liabilities 2.6m
Other Current Liabilities 1m
Non-Current Liabilities 1.7m
Other Non-Current Liabilities 1.7m
Efficiency
Fundamental Scores

YTEN Profitability Score
Profitability Due Diligence

Yield10 Bioscience Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Negative 1-Year Revenue Growth
Declining ROE
Declining ROIC
12/100
Profitability
Score

Yield10 Bioscience Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

YTEN Solvency Score
Solvency Due Diligence

Yield10 Bioscience Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
34/100
Solvency
Score

Yield10 Bioscience Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

YTEN Price Targets Summary
Yield10 Bioscience Inc

There are no price targets for YTEN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

YTEN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

YTEN Return Decomposition
Main factors of price return

What is price return decomposition?

YTEN Price
Yield10 Bioscience Inc

1M 1M
-19%
6M 6M
-89%
1Y 1Y
-85%
3Y 3Y
-96%
5Y 5Y
-100%
10Y 10Y
-100%
Annual Price Range
0.25
52w Low
0.2169
52w High
4.1
Price Metrics
Average Annual Return -37.76%
Standard Deviation of Annual Returns 27.97%
Max Drawdown -100%
Shares Statistics
Market Capitalization 3m USD
Shares Outstanding 11 864 000
Percentage of Shares Shorted 1.91%

Company Profile

Yield10 Bioscience Inc Logo
Yield10 Bioscience Inc

Country

United States of America

Industry

Biotechnology

Market Cap

3m USD

Dividend Yield

1.38%

Description

Yield10 Bioscience, Inc. operates as an agricultural bioscience company. The company is headquartered in Woburn, Massachusetts and currently employs 29 full-time employees. The company went IPO on 2006-11-10. The firm is developing the oilseed Camelina sativa (Camelina) as a platform crop for large scale production of low-carbon sustainable seed products. The firm focuses on petroleum replacement markets, in which it is developing Camelina oil for use as a biofuel feedstock and polyhydroxyalkanoates (PHA) bioplastics produced in Camelina seed for use as a biodegradable bioplastic; and food and nutrition markets, in which it is developing omega-3 (DHA+EPA) oils produced in Camelina seed for aquaculture, nutraceuticals and protein meal for animal feed markets. The company is engaged in the development of elite Camelina germplasm exhibiting herbicide tolerance, disease resistance and other traits that form improved elite Camelina varieties for the biofuel market. The firm's new seed product traits include the PHA bioplastic trait developed by the Company and the omega-3 (DHA+EPA) oil traits.

Contact

MASSACHUSETTS
Woburn
19 Presidential Way Ste 201
+16175831700.0
http://www.yield10bio.com/

IPO

2006-11-10

Employees

29

Officers

Co-Founder, Pres, CEO & Director
Dr. Oliver P. Peoples
Co-Founder & Independent Director
Dr. Anthony J. Sinskey Ph.D., Sc.D.
VP of Research & Chief Science Officer
Dr. Kristi D. Snell
VP of Planning & Corp. Communications and Sec.
Ms. Lynne H. Brum
VP of Fin., Chief Accounting Officer & Treasurer
Mr. Charles B. Haaser
Director of Bus. Analytics & Operations
Dr. Nicholas Renegar Ph.D.

See Also

Discover More